CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
79 hedge funds and large institutions have $166M invested in Cascadian Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 76 → 79 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
79
Holding in Top 10
1
Calls
$164K
Puts
$94K
Top Buyers
| 1 | +$1.86M | |
| 2 | +$1.69M | |
| 3 | +$1.02M | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$982K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$460K |
Top Sellers
| 1 | -$7.22M | |
| 2 | -$3.65M | |
| 3 | -$557K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$186K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$102K |